Current projects

We encourage prospective D/P's (donor/participants) to become involved in current and future studies. If a study listed does not apply to your particular situation we still invite you to register so that we may include you in our database and contact you for future studies.

We are looking for D/P's in the following categories:

ID # Required D/P's Enrolled D/P's Remaining D/P's Inclusion Criteria
323472 90 72 18 Whole Blood Units from HxV Negative Donors
323183 20 0 20 K3EDTA Plasma Collection in Streck Tubes from HxV Negative Donors
323062 20000 412 19588 Customer Samples kept in Biorepository (HBcT2 Sample Shipment from UMIA to BCW_Kelly K. Morocho)
322873 1 1 0 DBS Cards and Serum from a Specific Donor (DPID#185472)
322857 120 0 120 Prospective Collection from Normal Subject with Iron deficiency or Iron overload (Ferritin Project_Clinical Samples )
322841 600 0 600 Prospective Apparently Healthy Subject Blood Collection Protocol (Ferritin Project)
322611 13 13 0 Pre-selected HCV Positive samples from Inventory (Spiking Material)
322262 2 2 0 Pre-Selected HBV Positive samples with Genotype information from Inventory.
322089 8 8 0 Pre-Selected Covid Negative Plasma Samples from HxV negative donors.
322088 6 6 0 Pre-Selected Covid Positive Plasma Samples from HxV negative donors.
322064 50 46 4 Pre-Selected Plasma Normal Samples from Pediatric donors.
321794 50 50 0 Pre-Selected K2EDTA Plasma Normal Samples from donors vaccinated against Hepatitis B_Reactive for Anti-Hbs
321767 3 19 -16 Pre-Selected HIV and Syphilis Positive samples samples from Inventory (Co-Infected Samples)
321680 500 0 500 Prospective Healthy Subject Blood Collection Protocol (aTG Study)
321542 20 25 -5 Pre-Selected HxV Negative samples from Inventory
321261 60 60 0 Pre-Selected HxV Negative samples from Inventory
321260 50 10 40 Prospective collection from Healthy Donors
321237 20 5 15 Pre-Selected Treponema pallidum Antibody Positive samples from Inventory
321231 20 3 17 Pre-Selected HAV AB Positive samples from Inventory
321096 22 28 -6 Pre-Selected EBV positive samples (Antibodies)
320950 5 5 0 Pre-Selected RPR Positive plasma samples from Inventory
320753 20 0 20 Pre-Selected Trichomonas Positive samples from Inventory
320738 20 0 20 Pre-Selected Chlamydia and Gonorrhea Positive samples from Inventory (Co-Infected)
320706 20 5 15 Pre-Selected HIV, HCV and HBV Positive samples from Inventory (Co-Infected)
320546 1 1 0 Pre-Selected HCV Positive samples with elevated Viral Load from Inventory
320336 100 100 0 Nasopharyngeal & Nasal Swab Collection from Symptomatic Donors
320327 100 100 0 Self Collected Vaginal Swabs from Symptomatic Donors
320304 33 33 0 Pre-Selected Syphilis Positive Plasma Samples from Inventory
319608 20 20 0 Pre-Selected Gonorrhea Negative urine samples from Inventory
319607 20 20 0 Pre-Selected Gonorrhea Positive urine samples from Inventory
319565 80 31 49 HIV, HCV, HBV and Syphilis cassette Testing using samples from our Inventory.
318306 93 91 2 Pre-Selected CT, GC and TV urine Samples from Inventory
317251 100 48 52 Pre-Selected CMV samples with Viral Load
316979 100 100 0 Pre-Selected Treponema pallidum positive samples
316965 100 17 83 HxV-VL Testing in Abbott m2000
316334 100 4 96 Urine samples from CT/GC Positive Donors
316329 10 2 8 Self-collected vaginal swab samples from CT/GC Positive Donors
315345 380 288 92 Leftover Samples from VZV IgG Patients Testing Routine (from IRL)
- VZV Samples (All-comers)
250 unique D/P's
-VZV Samples (Pediatrics)
50 Donors: Age_2-12
50 Donors: Age_13-21
- VZV Negative Samples
30 unique D/P's
314103 10 10 0 Pre-Selected samples Positive for Toxo IgG in Serum matrix.
312456 1000 131 869 Protocol: COL-RESP-528_Testeng services for samples collected at external facilities
312021 237 78 159 Pre-Selected HIV-1 Positive (Low CD4 count) Samples from Inventory
311954 35 27 8 Fresh Whole Blood from HIV-1 Positive Donors
311816 600 264 336 Protocol: LIA-STI-497- Cobas CT/NG/MG Nucleic Acid Test for use on the Cobas Liat System: Clinical Performance Evaluation
311766 100 28 72 Prospective CoV-2, Flu A, Flu B, and RSV Positive Collection_TZC0031535/SACQ_0002973
311567 34 33 1 Pre-Selected Rubella IgG Non-Immune Serum Samples from Inventory
309853 5000 212 4788 Pre-Selected HxV Negative Samples from Inventory_20 mls to 40 mls (SRF_0003004)
309294 20 23 -3 Prospective Collection of SARS-CoV-2 Positive NP Samples
308929 1 1 0 Monkeypox Positive Serum Samples from Inventory
307884 50 107 -57 Prospective Whole Blood Collection with Specific HbA1c level TZC0031646
305552 1000 126 874 Protocol: COL-RESP-528 - Collection of Respiratory Swab Samples from Patients with Suspected Respiratory Tract Infections - Miami
303165 80 0 80 Prospective Rectal Swab Collection
301909 800 1007 -207 Abbott RealTime CT/NG Testing, Cepheid_248C
300305 745 672 73 Pre-Selected HBV Plasma Samples from Inventory (Project# HDV HBV RNA_BCW)
299865 30 301 -271 Nasal Collection Protocol for Flu A/FluB positive donors
299254 60 95 -35 Cervical and Vaginal Swabs from HPV Positive and Negative Donors
298305 10 5 5 Prospective Lesion Swab, Oropharyngeal Swab and Whole Blood Collection from Positives Monkeypox Donors
297859 25 32 -7 Prospective Whole Blood and PBMCs collected from Healthy Females (selected age, race and ethnicity)
296225 34 34 0 Pre-Selected HBV Plasma Samples from Inventory
294344 100 22 78 Prospective Collection for subjects suspected to be positive for Monkeypox
293753 60 15 45 Female Vaginal Sample Collection Protocol for CT/GC positive donors
293648 30 4 26 Prospective Collection for subjects with CoV-2, Flu A, Flu B, RSV
292590 10000 0 10000 A Multi-Site, Multi-Point, Prospective Collection Protocol in order to obtain Nasal Swab, Pharyngeal Swab, Vaginal Swab, Rectal Swab, Lesion Swab, Saliva Sample and/or Blood Samples from a positive or suspected positive D/Ps with Monkeypox
284336 200 10 190 Pre-Selected HCV Positive Samples from Inventory (19SUST056)
283190 200 113 87 Protocol No. LIA-STI-250 - cobas CT/NG/MG Nucleic acid test for use on the cobas Liat System: Feasibility Performance Evaluation
282803 5 4 1 Fresh Whole Blood from HIV-1 Positive Individuals
282613 100 0 100 Rapigen-001 - Clinical Study Protocol - BIOCREDIT COVID-19 Ag Home Test Nasal (Puerto Rico)
282610 10000 0 10000 A Multi Site, Longitudinal, Prospective Sample Collection Protocol in order to obtain Samples from Normal Healthy D/Ps
281675 20000 2904 17096 Customer Samples kept in Biorepository (CHIV Study 2011, Universiti of Miami, Zawadzki, Cassandra )
266931 120 17 103 PAS-19SUST053 Testing HBV VL (Abbott & Hologic)
266866 120 26 94 Protocol: FD-001 - Clinical Evaluation of the Fosun COVID-19 Ag Home Test In Symptomatic and Asymptomatic Subjects
261154 800 1892 -1092 Protocol: LIA-CoV-560 - cobas SARS-CoV-2 and cobas SARS-CoV-2 & Influenza A/B Nucleic acid tests for use on the cobas Liat® System: Clinical Performance Evaluation
251350 100 30 70 SARS-CoV-2 Positive Nasal, Oropharyngeal Dry Swab and Raw Saliva Collection Protocol
242206 5000 27473 -22473 COVID-19 Testing
239188 500 0 500 A Recurrent Multi Site, Longitudinal, Prospective Blood Collection Protocol in order to obtain Samples from D/Ps that have been Diagnosed or Suspected to have HIV, HBV, HCV, Syphilis, CMV, Toxo and/or Rubella
230530 20000 1295 18705 Customer Samples kept in Biorepository (CMVG Samples, Susan Rimpel)
228201 20000 466 19534 Customer Samples kept in Biorepository from Minneapolis Medical Research Foundation (MMRF)
227994 130 5 125 PAS-19SUST054 - HCV
226001 100 39 61 SARS-CoV-2 Positive Nasal, Oropharyngeal Dry Swab and Raw Saliva Collection Protocol
225611 10000 0 10000 A Multi Site, Longitudinal, Prospective Collection Protocol in order to obtain Samples from Normal Healthy D/Ps
224514 600 76 524 Initiative to Screen Potential Study Candidates (SUST)
195775 20000 1380 18620 Customer Samples kept in Biorepository from HBcT2 [JRID#93116]
190737 5000 53 4947 SARS-CoV-2 Survey (PT)
182696 1000 355 645 Protocol: COL-RESP-528 - Collection of Respiratory Swab Samples from Patients with Suspected Respiratory Tract Infections
175121 1000 27 973 CBC Initiative
173768 10000 0 10000 A Multi-Site, Multi-Point, Prospective Collection Protocol in order to obtain Saliva, Sputum, Nasal, Pharyngeal, Blood and/or Finger Stick Specimens from SARS-CoV-2 positive subjects
152854 10000 0 10000 A Multi Site, Longitudinal, Prospective Blood Collection Protocol in order to obtain Samples from Normal Healthy D/Ps
151681 5000 3 4997 Refer to Processing Instructions @ Attachment Tab
149547 5000 260 4740 Refer to Processing Instructions @ Attachment Tab
TESTS TO SELECT PER LOCATION - REFER TO ATTACHMENT TAB
148791 5000 40 4960 Refer to Processing Instructions @ Attachment Tab
145574 5000 105 4895 Refer to Processing Instructions @ Attachment Tab
144620 5000 47 4953 Refer to Processing Instructions @ Attachment Tab
142755 5000 110 4890 Refer to Processing Instructions @ Attachment Tab
141914 1000 7 993 HIV Initiative
141493 5000 55 4945 HCV Viral Load and Genotype Survey (PT)
141491 5000 24 4976 HBV Viral Load Survey (PT)
141490 5000 55 4945 HIV Viral Load Survey (PT)
140923 5000 100 4900 Refer to Processing Instructions @ Attachment Tab
140922 5000 55 4945 Refer to Processing Instructions @ Attachment Tab
140530 5000 10 4990 Rubella IgG (AAB - PT)
140528 5000 6 4994 ToRCH (AAB - PT)
139409 5000 117 4883 Pregnancy (PT)
137933 5000 0 5000 A Recurrent Multi Site, Longitudinal, Prospective Blood Collection Protocol in order to obtain Samples from D/Ps that have been Diagnosed or Suspected to have HIV from Cameroon
129688 200 163 37 EBV / EBK Samples from National Center of Urology - Tbilisi, Georgia
129538 1000 309 691 RPR Initiative
128402 1000 64 936 CBC Initiative
124266 5000 143 4857 A Recurrent Multi Site, Longitudinal, Prospective Blood Collection Protocol in order to obtain Samples from D/Ps that have been Diagnosed or Suspected to have HIV from Cote D'Ivoire
122931 5000 3357 1643 A Recurrent Multi Site, Longitudinal, Prospective Blood Collection Protocol in order to obtain Samples from D/Ps that have been Diagnosed or Suspected to have HIV, HBV, HCV, Syphilis, CMV, Toxo and/or Rubella
122654 5000 171 4829 A Recurrent Multi Site, Longitudinal, Prospective Blood Collection Protocol in order to obtain Samples from D/Ps that have been Diagnosed or Suspected to have HIV from Swaziland
120851 140 26 114 A Recurrent Multi Site, Longitudinal, Prospective Blood Collection Protocol in order to obtain Samples from D/Ps that have been Diagnosed or Suspected to have HCV
109382 100 32 68 A Recurrent Multi Site, Longitudinal, Prospective Blood Collection Protocol in order to obtain Samples from D/Ps that have been Diagnosed or Suspected to have HIV
109381 300 6 294 A Recurrent Multi Site, Longitudinal, Prospective Blood Collection Protocol in order to obtain Samples from D/Ps that have been Diagnosed or Suspected to have HCV
108692 1000 1062 -62 HxV Testing Initiative
102419 1000 494 506 Samples on hold for future shipments to China
98830 10000 0 10000 A Multi-Site, Multi-Point, Prospective Collection Protocol in order to obtain PAP, Endocervical Swab, Vaginal Swab, Nasal Swab, Pharyngeal Swab, Rectal Swab, Urethral Swab and/or Urine Samples
98084 1000 577 423 CBC Qualifying Job Request
96278 195 185 10 A Recurrent Multi Site, Longitudinal, Prospective Blood Collection Protocol in order to obtain Samples from D/Ps that have been Diagnosed or Suspected to have HIV, HBV, HCV, Syphilis, CMV, Toxo and/or Rubella
96055 40 1859 -1819 Hologic Panels for HIV and HCV
94841 500 1 499 A Recurrent Multi Site, Longitudinal, Prospective Blood Collection Protocol in order to obtain Samples from D/Ps that have been Diagnosed or Suspected to have HCV - LGR
80997 5000 428 4572 A Recurrent Multi Site, Longitudinal, Prospective Blood Collection Protocol in order to obtain Samples from D/Ps that have been Diagnosed or Suspected to have HIV from Cameroon
78138 300 140 160 A Recurrent Multi Site, Longitudinal, Prospective Blood Collection Protocol in order to obtain Samples from D/Ps that have been Diagnosed or Suspected to have HCV
78137 300 414 -114 A Recurrent Multi Site, Longitudinal, Prospective Blood Collection Protocol in order to obtain Samples from D/Ps that have been Diagnosed or Suspected to have HIV
74261 10000 0 10000 A Recurrent Multi Site, Longitudinal, Prospective Blood Collection Protocol in order to obtain Samples from D/Ps that have been Diagnosed or Suspected to have HIV, HBV, HCV, Syphilis, CMV, Toxo and/or Rubella
68258 10000 0 10000 A Multi Site, Longitudinal, Prospective Blood Collection Protocol in order to obtain Samples from Normal Healthy D/Ps
63868 1000 1146 -146 Blinded HIV/HBV/HCV Prospective Blood Collection Protocol from Guinea Bissau
56717 20000 0 20000 A Multi-Site, Multi-Point, Prospective Collection Protocol in order to obtain PAP , Endocervical, Vaginal, Nasal and/or Urine Samples
55075 10000 28 9972 Beta HCG Matched Set Prospective Blood Collection Protocol
54664 200 148 52 Random Cadaveric Samples
27615 15000 633 14367 Prospective Blood Collection Protocol in order to Collect Samples from Donor/Participants (D/Ps) in Low Socio-Economic Regions of the World
26761 10000 482 9518 HIV Positive Time Stability Whole Blood Collection Protocol
10694 3000 2234 766 HCV Longitudinal Prospective Blood Collection Protocol
10693 3000 369 2631 HBV Multi-Point Prospective Blood Collection Protocol
8568 300 1733 -1433 Positive Plasma Units from Blood Centers Around the World (HIV, HBsAg & HCV)



BCW helps clinicians during their research process through collection sites and D/P availability. Our collection sites have been duly inspected and adhere to our Good Manufacturing Practices thus ensuring reliability during the collection process. In addition to this we provide training seminars as part of our Quality Assurance in order to maintain the level of quality that our customers are accustomed to.

You will be invited to participate in research studies for the advancement of diagnostic technologies. Participation in these studies is voluntary. Our D/P's are informed of what the research projects are about and are given an Informed Consent, which evidences their willingness to participate. In order to protect our D/P's we never divulge your identity to the research facilities thus guaranteeing D/P confidentiality.



Contact us to learn more